Mobile menu not yet fully implemented
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Published on | 2 months ago
Programmes Agro-Food, Environment MissionsThe third Water4all call on the topic “Water and Circular Economy” will be open on the 12th of September 2024.
The relevant subthemes of this call:
This call will be launched by the Water4all (Water Security for the Planet) partnership which is co-funded by the European Union within the frame of the Horizon Europe programme and includes a collaboration with VLAIO and FWO to allow more projects to be approved.
For more information, please access the dedicated pages below or contact your NCP.
https://www.vlaio.be/nl/nieuws/water4all-oproep-met-als-thema-water-en-circulaire-economie.
2024-11-12
|
1 week ago |
Call for technical assistance under the mission on ocean and waters now open |
2024-11-05
|
2 weeks ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
2024-10-03
|
1 month ago |
Update: Joint Call on "Water for Circular Economy" open |
2024-09-25
|
1 month ago |
Number of submitted proposals - HORIZON-MISS-2024-NEB-01 |
2024-09-25
|
1 month ago |
Submitted proposals - Cancer Mission 2024 Call |
2024-09-20
|
2 months ago |
Strategic Technologies for Europe Platform survey |
2024-09-20
|
2 months ago |
Database on transnational and virtual access to research infrastructures for all scie... |
2024-09-20
|
2 months ago |
New calls for Mission "Climate neutral and smart cities" are now open |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.